Cancer patients are too often paying exorbitant prices for medications that offer no real benefits in quality or length of life, according to Dr. Vinay Prasad, hematology oncologist at the Oregon Health and Sciences University.
Prasad spoke Wednesday in a Webinar offered by
Breast Cancer Action, a California-based group that advocates for less toxic cancer treatments and a less toxic environment that contributes to cancer incidence. The group takes no money from drug companies.
See the Webinar.
Some highlights and what this all means for you:
The cost of cancer drugs has risen far above the cost of inflation. Prasad noted that the cost of cancer treatment in 1975 was $129 per month. That would be about $600 today, adjusted for inflation. However, the average price of new cancer drugs today is about $10,000 per month. That is in line with the cost of Jakafi (ruxolitinib), which many ET patients take.